Publication | Open Access

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Metabolic SyndromeDiabetes ManagementOdyssey OutcomesCardiovascular DiseaseCoronary Artery DiseaseDiabetesAcute Coronary SyndromeAcute Myocardial InfarctionMedicineMetabolic OutcomesCardiologyEmergency MedicineAnesthesiologyMyocardial Infarction